Home
Conditions
Graft vs Host Disease

Clinical trial condition

Graft vs Host Disease

Explore clinical trials studying Graft vs Host Disease. Study availability and eligibility vary by location and protocol.

467 public trials 74 recruiting studies

Refine in advanced search Browse all conditions

Graft vs Host Disease trial results

Completed

Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

NCT00813124

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +13 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations: Hackensack University Medical Center Hackensack, New Jersey, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

NCT02683525

Conditions: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Immune System Diseases
Locations: Indiana University Health Hospital Indianapolis, Indiana, United States

Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention

NCT02423915

Conditions: Graft vs Host Disease, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002).

NCT04687982

Conditions: Bone Marrow Transplant Complications, Bone Marrow Transplant Infection, Graft vs Host Disease, +9 more
Locations: Istituto Clinico Humanitas Rozzano, MI, Italy

View Trial Details

Completed

Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT

NCT02876679

Conditions: Graft vs Host Disease, Immune System Diseases
Locations: Saint Antoine Hospital - Hematology Department Paris, France

View Trial Details

Completed

Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin

NCT00822770

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +15 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

G-CSF Moblized Peripheral Harvest for Poor Engraftment After Stem Cell Transplantation

NCT01857336

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Immune System Diseases, +2 more
Locations: Peking University Institute of Hematology Beijing, Beijing Municipality, China

View Trial Details

Completed

Anti-thymocyte Globulins for Graft-versus-host Disease Prophylaxis

NCT01856803

Conditions: Graft vs Host Disease, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Peking university people's hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome

NCT01287078

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Graft vs Host Disease

Graft vs Host Disease trial results

Related conditions